RemeGen Co., Ltd.
HKEX:9995.HK
19.36 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 1,076.13 | 767.775 | 1,423.902 | 0 | 0 | 11.321 |
| Cost of Revenue
| 253.136 | 269.939 | 67.163 | 0 | 0 | 8.932 |
| Gross Profit
| 822.994 | 497.836 | 1,356.739 | 0 | 0 | 2.389 |
| Gross Profit Ratio
| 0.765 | 0.648 | 0.953 | 0 | 0 | 0.211 |
| Reseach & Development Expenses
| 1,306.307 | 982.08 | 710.973 | 465.821 | 352.066 | 216.438 |
| General & Administrative Expenses
| 313.673 | 272.542 | 219.84 | 217.623 | 32.779 | 9.37 |
| Selling & Marketing Expenses
| 775.185 | 440.696 | 262.967 | 24.18 | 0.621 | 0 |
| SG&A
| 1,088.858 | 713.238 | 482.807 | 241.803 | 33.4 | 9.37 |
| Other Expenses
| -12.457 | -143.403 | -140.125 | -70.382 | 3.282 | 8.051 |
| Operating Expenses
| 2,325.34 | 1,551.915 | 1,053.655 | 637.242 | 388.748 | 233.859 |
| Operating Income
| -1,545.392 | -993.066 | 281.922 | -668.548 | -386.625 | -231.355 |
| Operating Income Ratio
| -1.436 | -1.293 | 0.198 | 0 | 0 | -20.436 |
| Total Other Income Expenses Net
| 34.163 | -5.764 | -5.664 | -29.273 | -43.655 | -38.593 |
| Income Before Tax
| -1,511.229 | -998.83 | 276.258 | -697.821 | -430.28 | -269.948 |
| Income Before Tax Ratio
| -1.404 | -1.301 | 0.194 | 0 | 0 | -23.845 |
| Income Tax Expense
| 61.506 | -0.993 | 5.664 | 29.273 | 43.655 | -1.462 |
| Net Income
| -1,511.229 | -997.837 | 276.258 | -727.094 | -473.935 | -268.486 |
| Net Income Ratio
| -1.404 | -1.3 | 0.194 | 0 | 0 | -23.716 |
| EPS
| -2.8 | -1.88 | 0.57 | -1.78 | -0.99 | -0.56 |
| EPS Diluted
| -2.8 | -1.88 | 0.57 | -1.78 | -0.99 | -0.56 |
| EBITDA
| -1,243.607 | -806.695 | 402.394 | -590.882 | -343.853 | -208.716 |
| EBITDA Ratio
| -1.156 | -1.051 | 0.283 | 0 | 0 | -18.436 |